8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 18, 2003

DaVita Inc.

(Exact name of registrant as specified in its charter)

Delaware	1-4034	51-0354549
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

21250 Hawthorne Boulevard, Suite 800, Torrance, California	90503
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (310) 792-2600

Item 5. Other Events and Regulation FD Disclosure

Attached hereto as Exhibit 99.1 is a press release issued on August 18, 2003 announcing the closing of the partial redemption of $200,000,000 principal amount of the Registrant’s 7% Convertible Subordinated Notes due 2009, which is incorporated by reference herein.

Item 7. Financial Statements and Exhibits.

(c) Exhibits

Exhibit No.	Description
99.1	Press Release, dated August 18, 2003.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	DAVITA INC.
Date: August 18, 2003	/s/    Patrick Broderick
	Patrick Broderick Vice President, Secretary and General Counsel

EX-99.1

Exhibit 99.1

Contact:	LeAnne Zumwalt
	Investor Relations DaVita Inc. 310 750-2072

DAVITA INC. COMPLETES PARTIAL REDEMPTION OF

7% CONVERTIBLE SUBORDINATED NOTES

TORRANCE, CA, August 18, 2003—DaVita Inc. (NYSE: DVA) today announced that it completed a call for a partial redemption of $200,000,000 principal amount of its 7% Convertible Subordinated Notes due 2009 (the “Notes”). All $200,000,000 principal amount of the Notes were redeemed for $208,400,000 in cash plus accrued interest. As of August 18, 2003, $145,000,000 principal amount of the Notes are outstanding.

DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company operates kidney dialysis centers and home peritoneal dialysis programs domestically in 33 states, as well as Washington, D.C. As of June 30, 2003, DaVita provides services at 539 outpatient facilities for 47,000 patients, including 3,300 patients in 29 centers under management.